Biosyent Inc (BIOYF)
7.49
0.00 (0.00%)
USD |
OTCM |
Jul 01, 16:00
Biosyent Total Liabilities (Quarterly): 4.029M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 4.029M |
December 31, 2023 | 5.103M |
September 30, 2023 | 5.036M |
March 31, 2023 | 3.94M |
December 31, 2022 | 5.248M |
September 30, 2022 | 4.402M |
June 30, 2022 | 4.076M |
March 31, 2022 | 4.679M |
December 31, 2021 | 4.402M |
September 30, 2021 | 5.482M |
June 30, 2021 | 4.463M |
March 31, 2021 | 4.358M |
December 31, 2020 | 5.313M |
September 30, 2020 | 4.302M |
June 30, 2020 | 3.999M |
March 31, 2020 | 3.871M |
December 31, 2019 | 3.958M |
September 30, 2019 | 3.50M |
June 30, 2019 | 2.467M |
March 31, 2019 | 2.290M |
December 31, 2018 | 2.630M |
September 30, 2018 | 2.181M |
June 30, 2018 | 2.361M |
March 31, 2018 | 1.929M |
December 31, 2017 | 2.300M |
Date | Value |
---|---|
September 30, 2017 | 1.839M |
June 30, 2017 | 1.817M |
March 31, 2017 | 1.566M |
December 31, 2016 | 1.870M |
September 30, 2016 | 1.316M |
June 30, 2016 | 1.646M |
March 31, 2016 | 1.164M |
December 31, 2015 | 1.770M |
September 30, 2015 | 1.482M |
June 30, 2015 | 1.485M |
March 31, 2015 | 1.333M |
December 31, 2014 | 2.140M |
September 30, 2014 | 1.620M |
June 30, 2014 | 1.218M |
March 31, 2014 | 0.8794M |
December 31, 2013 | 1.162M |
September 30, 2013 | 1.255M |
June 30, 2013 | 1.267M |
March 31, 2013 | 0.7218M |
December 31, 2012 | 0.8176M |
September 30, 2012 | 1.159M |
June 30, 2012 | 0.7907M |
March 31, 2012 | 0.6325M |
December 31, 2011 | 0.4137M |
September 30, 2011 | 0.6541M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
3.50M
Minimum
Sep 2019
5.482M
Maximum
Sep 2021
4.454M
Average
4.380M
Median
Total Liabilities (Quarterly) Benchmarks
Acasti Pharma Inc | 11.56M |
Aurinia Pharmaceuticals Inc | 170.11M |
Edesa Biotech Inc | 2.151M |
Lexaria Bioscience Corp | 0.2042M |
Xenon Pharmaceuticals Inc | 31.32M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 29.60M |
Shareholders Equity (Quarterly) | 25.57M |
Current Ratio | 7.718 |